| No. | Drug Name | Active Ingredient | Date | What It’s Used For |
| 23. | Orbactiv | oritavancin | 8/6/2014 | To treat adults with skin infections
0 u/ l/ w5 X. M Press Release |
| 22. | | empagliflozin | 8/1/2104 | To improve gylcemic control in adults with type 2 diabetes
& J7 g8 s. J* K/ S) g0 V6 Y2 J- h% e Press Release |
| 21. | | olodaterol | 7/31/2014 | To treat chronic obstructive pulmonary disease( W" r7 h- F5 }
Press Release |
| 20. 9 s) l9 \6 n2 r
" a9 A# H2 Q# W, R: g0 z: H
| | idelalisib | 7/23/2014 | To treat patients with trhee types of blood cancers8 w, j* b/ I" @4 D G8 H5 U$ R
Press Release |
| 19. | Kerydin5 o( L# p% E# u, T, C. q) \
6 w3 C) n G* R3 f9 N) | | tavaborole | 7/7/2014 | For the topical treatment of onychomycosis of the toenails & g$ R% x" m) Q& W( N- w
(No Press Release) |
| 18. | | belinostat | 7/3/2014 | To treat patients with peripheral T-cell lymphoma (PTCL) * M3 r( Q1 D0 G% _: _. W
Press Release |
| 17. | | tedizolid phosphate | 6/20/2014 | To treat adults with skin infections( p0 N1 D, U9 |& B" b7 R, h* ?
Press Release |
| 16. | Jublia* S& N- f! w# u" b
( i7 B. E5 \, u8 T4 o | efinaconazole | 6/6/2014 | Treat mild to moderate onychomycosis (fungal infection)
) I2 g# x7 F" _2 e8 r. E' R No Press Release |
| 15. | Dalvance: k. R" O/ [8 O9 \7 H Y
" N/ P v7 X" i `
| dalbavancin | 5/23/2014 | To treat adults with skin infections
+ D a H4 K9 K! [7 n1 c Press Release |
| 14. | Entyvio
+ l' j5 U2 a6 x8 @6 o
4 M' C' z4 ?( K7 Z; A$ K | vedolizumab | 5/20/2014 | To treat adult patients with moderate to severe ulcerative colitis and adult patients with moderate to severe Crohn‘s disease5 H* ~) ^5 t. H4 c8 K3 o
Press Release |
| 13. | Zontivity7 S* j& }/ {8 d8 ^- K3 T
, N8 t0 z! V% M | vorapaxar | 5/8/2014 | To reduce the risk of heart attacks and stroke in high-risk patients% Y7 P! u$ J" O( k% h
Press Release |
| 12. | | ceritinib | 4/29/2014 | To treat patients with a certain type of late-stage (metastatic) non-small cell lung cancer (NSCLC)9 h2 v2 @4 |# O% W( }* y' \
Press Release |
| 11. | | siltuximab | 4/23/2014 | To treat patients with multicentric Castleman’s disease (MCD), a rare disorder similar to lymphoma (cancer of the lymph nodes)1 x1 n5 k! X7 C" R( _
Press Release |
| 10. | | ramucirumab | 4/21/2014 | To treat patients with advanced stomach cancer or gastroesophageal junction adenocarcinoma0 ]% y/ G& L9 i( n. u
Press Release |
| 9. | | albiglutide | 4/15/2014 | To improve glycemic control, along with diet and exercise, in adults with type 2 diabetes1 u2 I4 m* z. I h" v- |
Press Release |
| 8. | | apremilast | 3/21/2014 | To treat adults with active psoriatic arthritis (PsA)4 i; r6 D8 p& d. N
Press Release |
| 7. | | miltefosine | 3/19/2014 | To treat a tropical disease called leishmaniasis
8 |) d) e9 U4 g/ }3 ~# @( b Press Release |
| 6. | | florbetaben F 18 injection | 3/19/2014 | For Positron EmissionTomography (PET) imaging of the brain |
| 5. | | metreleptin for injection | 2/24/2014 | To treat the complications of leptin deficiency
8 M: A0 N6 T# K- t" p" N' g( @ Press Release |
| 4. | | droxidopa | 2/18/2014 | To treat neurogenic orthostatic hypotension (NOH)* S0 Z+ @8 [) q' I" m/ |) }$ X7 ^5 {
Press Release |
| 3. | | elosulfase alfa | 2/14/2014 | Treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome)
: B; |& t0 g, j" M, Q) d Press Release |
| 2. | | tasimelteon | 1/31/2014 | To treat non-24- hour sleep-wake disorder (“non-24”) in totally blind individuals. Non-24 is a chronic circadian rhythm (body clock) disorder in the blind that causes problems with the timing of sleep.Press Release |
| 1. | | dapaglifozin | 1/8/2014 | To improve glycemic control, along with diet and exercise, in adults with type 2 diabetes# [- V9 x, D7 U6 ~4 V5 _/ L" m
Press Release |
|手机版|药群论坛
( 蜀ICP备15007902号 )
收藏
支持
反对